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Previously, the connection between cell proliferation and Wnt signaling focused on transcriptional activation
of cyclin D1 and c-myc, which control the G1/S transition of the cell cycle. In this issue of Developmental Cell,
the Niehrs group demonstrates mitotic activation of Wnt signaling by a novel Cdk/cyclin complex containing
Cdk14 (PFTK1) and cyclin Y.Wnts are secreted glycoproteins that bind
to Frizzled receptors and induce oligo-
merization of the coreceptors LRP5/6
(Low-density lipoprotein receptor Related
Proteins) to activate b-catenin-dependent
transcription. In the absence of Wnt, Axin
works as a scaffold forming a complex
including glycogen synthase kinase 3
(GSK3) and casein kinase 1 (CK1), which
phosphorylate b-catenin, resulting in
binding by the ubiquitin ligase SCFb-Trcp,
which targets b-catenin for proteasomal
degradation (Frescas and Pagano, 2008).
Wnt-activated LRP5/6 binds the Axin
complex, ultimately liberating b-catenin
from its influence. In this situation, b-cate-
nin remains unphosphorylated and con-
sequently accumulates and translocates
to the nucleus, where it activates TCF/
LEF-mediated transcription. LRP5/6 con-
tains five PPPSP motifs in the intracellular
domain, which are flanked by clusters of
CK1 phosphorylation sites. For example,
S1490 (in the most N-terminal PPPSP
motif) is flanked by a number of sites
(T1479, T1493, S1496, and T1499) that
are targets of CK1. Phosphorylation of
S1490 primes CK1-dependent phos-
phorylation events. Collectively, these
phosphorylation events are crucial for
Axin recruitment and stabilization of
b-catenin, making information about the
S1490-kinase vital to the understanding
of LRP5/6 regulation and Wnt signaling
as a whole (MacDonald et al., 2009).
However, LRP5/6 phosphorylation is
complicated by the fact that it responds
not only to the initial Wnt stimulus, but
also to an intracellular feedback loop, in
which the kinases of the Axin complex,
once recruited to LRP5/6, also phosphor-ylate and activate the coreceptor. In
addition, the intracellular Wnt effector
Dishevelled (Dvl) binds to the PIP5KI
kinase, inducing PIP2 production, which
mediates receptor aggregation, binding
of the Axin complex, and, ultimately,
LRP5/6 phosphorylation (MacDonald
et al., 2009). Phosphorylation of S1490
was thought to be mediated by GSK3,
but there were indications that other
kinases could phosphorylate this site too.
Now, Davidson et al. (2009) have identi-
fied Cdk14(PFTK1)/cyclin Y as a S1490
kinase.
Cyclin-dependent kinases (Cdks) are
a family of 20 protein kinases that regulate
cell cycle progression (Cdk1, Cdk2,
Cdk3, Cdk4, and Cdk6), transcription
(Cdk7, Cdk8, Cdk9, and Cdk10), differen-
tiation (Cdk5), and other processes [for
reviews see Malumbres et al., 2009;
Morgan, 2007; Satyanarayana and Kaldis,
2009]. Little is known about Cdk11–20,
and in many cases, the regulatory
cyclin subunits have not been identified.
Recently, it was reported that Cdk14
(PFTK1) binds to cyclin Y (Jiang et al.,
2009). By analogy, Cdk15 (PFTK2) and
cyclin Y-like 1 form a similar complex
that could share its substrate specificity
with Cdk14/cyclin Y. LRP5/6 is the first
in vivo substrate of Cdk14/Cdk15 that
has been identified (Davidson et al.,
2009). Intriguingly, S1490 is located in
a region (PPPSPAT) that is different from
the canonical Cdk phosphorylation motif
(S/TPXK/R). Thus, more detailed studies
of the phosphorylation consensus site for
Cdk14/Cdk15 would be desirable in the
future. Interestingly, Cdk14 is expressed
predominantly in mitosis, concurrentDevelopmental Cell 17, Dwith the peak in cyclin Y levels, although
low expression can also be detected in
other cell cycle phases. The peak expres-
sion of Cdk14 and cyclin Y coincides with
the peak in S1490 phosphorylation,
indicating that Wnt signaling is active
and effective in mitosis, which is sup-
ported by the activation of a Wnt reporter.
It is possible that, in mitosis, Cdk14/cyclin
Y complexes phosphorylate additional
substrates both in the Wnt pathway
(e.g., Apc, Axin, others) and in other
pathways, and future studies will need to
address this point.
Phosphorylation of LRP5/6 is just one
step in the Wnt signaling pathway, but it
seems to be an important event, since
S1490 phosphorylation primes LRP5/6
to be phosphorylated by CK1 on many
more sites. Nevertheless, this phosphory-
lation is not an isolated event—it
is part of a sequence of events that
includes Wnt-mediated Frizzled/LRP5/6
interactions, Dvl-mediated receptor clus-
tering, Dvl/PIP5K1/PIP2-induced receptor
aggregation, and Axin complex binding
to LRP5/6. It is still unclear how the
sequence of these events is orchestrated
and how the timing of LRP5/6 phosphory-
lation is determined. For example, Cdk14/
cyclin Y complexes are membrane bound
and must somehow be brought in close
proximity to LRP5/6. This process could
be achieved by randommembranemove-
ments or regulated by lipid rafts and
additional cofactors. In addition, it would
be interesting to know whether Cdk14/
cyclin Y is activated in a regulated manner
or whether its activity is mostly deter-
mined by its expression pattern and/or
timing.ecember 15, 2009 ª2009 Elsevier Inc. 749
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can phosphorylate LRP5/6 on S1490,
leading to questions of priority. Do both
kinases phosphorylate LRP5/6 in vivo, or
is one of these kinases the predominant
source of S1490 phosphorylation? LRP5/
6 contains five PPPSP motifs, and David-
sonet al. focusonly on themotif containing
S1490. Therefore, it is possible that Cdk14
does not phosphorylate all five PPPSP
motifs, despite that fact that these do-
mains display similar amino acid se-
quences. In fact, GSK3 could share the
responsibility of phosphorylating certain
specific domains with Cdk14. Another
possibility is that, depending on the envi-
ronment or cell typeorWnt familymember,
eitherCdk14orGSK3couldphosphorylate
the five PPPSP motifs. All these questions
will need to be addressed in the future.
Apart from cyclin D1 and c-myc, Wnt-
based regulation of the cell cycle appears
to occur through microtubule binding,
mediated by Apc, EB1, andGSK3 (Angers
and Moon, 2009; McCartney and Nathke,
2008; Salinas, 2007). This pathway not750 Developmental Cell 17, December 15, 20only affects the cytoskeleton and polarity,
but it also affects spindle alignment,
spindle position, and the mitotic spindle
checkpoint. The coupling of Wnt signaling
and mitosis at the level of LRP5/6
phosphorylation is a novel and intriguing
concept. Obviously, it is rather unlikely
that only mitotic cells are susceptible to
Wnt signaling. It is more likely that the
efficiency of Wnt signaling is increased
in mitosis. At the moment, it is not clear
why Wnt signaling should be more
efficient in mitosis, a phase when many
processes cease due to the cell dividing.
For example, transcription is reduced to
very low levels during mitosis, although
transcriptional readouts of Wnt signaling
seem to peak during this phase. The
current study suggests that Wnt signaling
promotes proliferation not only through
cyclin D1 and c-myc in G1/S phase,
but also during mitosis via unknown
targets. As we adjust to this novel con-
cept, the broader implications on both
mitosis and Wnt signaling will have to be
considered.09 ª2009 Elsevier Inc.REFERENCES
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Moellering et al. recently reported that a cell-permeable ‘‘stapled’’ synthetic peptide of the Notch coactivator
Mastermind is a potent dominant-negative inhibitor of oncogenic Notch signaling in T cell acute lympho-
blastic leukemia. This new class of inhibitor may find broad utility in blocking protein-protein interactions
that underlie many human diseases.TheNotch signaling pathway is transiently
induced during development to control
cell proliferation and differentiation (Aster
et al., 2008). In this pathway, binding
of extracellular ligands to the Notch1
receptor causes the proteolytic cleavage
and release of the Notch1 intracellular
domain (NICD). The short-lived NICD
protein translocates to the nucleus, where
it binds to Suppressor of Hairless [Su(H)]
CSL DNA-binding proteins to activate
downstream target genes (Figure 1).Loss of the normal cellular restraints on
Notch receptor processing and NICD
stability in the nucleus leads to an inappro-
priate reactivation in Notch signaling in
T cell acute lymphoblastic leukemia
(T-ALL) and several other cancers. Notch
signaling can be inhibited by chemical
inhibitorsof thegamma-secretasecomplex
(GSIs), which cleave the Notch1 receptor;
however, chronic disruption of Notch
signalingcombinedwithoff-targetactivities
have limited thepotential therapeuticuseofthese compounds and prompted a search
formore selective inhibitors of the pathway.
A different approach was suggested
from high-resolution structures of the
Notch enhancer complex, which revealed
a novel shallow groove that is created
upon binding of NICD to CSL (Nam
et al., 2006). This shared interface creates
a cavity that recruits Mastermind-like
(MAML) coactivators (Saint Just Ribeiro
and Wallberg, 2009) to the enhancer
complex. A 62 amino acid (aa) a-helical
